Bimix #3 in Vial recalled over sterility concerns
- Recall date
- September 12, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- KRS Global Biotechnology, Inc recalls Bimix #3 (Papaverine HCl 30 mg/mL/Phentolamine Mesylate 3 mg/mL) in 5 mL Vial, Rx Only, KRS Global Biotechnology 791 Pa…
- Recall number
- D-0043-2020
- FDA classification
- Class II
- Brand / firm
- KRS Global Biotechnology, Inc
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bimix #3 (Papaverine HCl 30 mg/mL/Phentolamine Mesylate 3 mg/mL) in 5 mL Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676500
Get recall alerts
Free email alert whenever KRS Global Biotechnology, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: KRS Global Biotechnology, Inc